CME webinar series: Addiction Care for the Non-Addiction Provider
Sep. 2022Education/Webinars
"CME webinar series: Addiction Care for the Non-Addiction Provider
September is National Recovery Month, and you are invited to watch a timely, CME-accredited webinar series on the topic. Michael Lynch, MD, Medical Director, Pittsburgh Poison Center; Medical Director, UPMC Health Plan Substance Use Disorder Services; and Associate Professor of Emergency Medicine, Toxicology, Pediatrics, and Addiction at the University of Pittsburgh, leads this four-part series.
Watch these recorded webinars to build your knowledge base:
*Provider is responsible for verifying CME eligibility. *This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
-
Part 1: Screening and initial intervention
Learn about the physiology, stigma, and effects of substance use disorder, among other topics related to screening and intervention. -
Part 2: Alcohol use disorder management
Learn about medication management and non-medication interventions, among other aspects of alcohol use disorder. -
Part 3: Opioid use disorder management
Learn about recommending medications for opioid use disorder (MOUD) and different MOUD options, among other aspects of opioid use disorder. -
Part 4: Overview of management and available resources
Learn about continuum of care for a patient with a substance use disorder including available resources to assist non-addiction providers to meet the needs of these patients.
*Provider is responsible for verifying CME eligibility. *This activity is approved for the following credit: AMA PRA Category 1 Credit™ and ANCC. Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity."
Recent Announcements
October 2025 UPMC for You and UPMC Community HealthChoices formulary update
Effective Oct. 1, 2025, Xifaxan and Retin-A (cream, gel) will no longer be covered by UPMC for You and UPMC Community HealthChoices due to nonparticipation in the Medicaid Drug Rebate Program.Oct. 2025Pharmacy Updates
Voluntary nationwide recall: Ocaliva (Intercept – September)
Intercept Pharmaceuticals, Inc. is voluntarily withdrawing Ocaliva® (obeticholic acid) from the market. Ocaliva is used to treat a rare liver disease called primary biliary cholangitis (PBC).Oct. 2025Pharmacy Updates
HelpScript service helps patients enroll in manufacturer copay assistance programs
End-to-end provider support helps ensure a smooth submission processOct. 2025Important Notices